Rule/Regulation Violated:
R9-10-120. Opioid Prescribing and Treatment
F. For a health care institution where opioids are administered as part of treatment or where a patient is provided assistance in the self-administration of medication for a prescribed opioid, including a health care institution in which an opioid may be prescribed or ordered as part of treatment, a medical director, a manager as defined in R9-10-801, or a provider, as applicable to the health care institution, shall:
4. Except as provided in subsection (H), ensure that an individual authorized by policies and procedures to administer an opioid in treating a patient or to provide assistance in the self-administration of medication for a prescribed opioid:
a. Before administering an opioid or providing assistance in the self-administration of medication for a prescribed opioid in compliance with an order as part of the treatment for a patient, identifies the patient's need for the opioid;
b. Monitors the patient's response to the opioid; and
c. Documents in the patient's medical record:
i. An identification of the patient ' s need for the opioid before the opioid was administered or assistance in the self-administration of medication for a prescribed opioid was provided, and
ii. The effect of the opioid administered or for which assistance in the self-administration of medication for a prescribed opioid was provided.
Evidence/Findings:
Based on record review, observation, documentation review, and interview, for one of two residents reviewed, who received opioid medication, without an active malignancy or an end of life condition, the manager failed to ensure an individual authorized to administer opioids documented in the resident's medical record; an identification of the resident's need for the opioid before the opioid was administered, and the monitoring of the effect of the opioid administered. The deficient practice posed a risk to a resident's health and safety if the facility did not appropriately assess and monitor opioid administration for a resident.
Findings include:
1. In record review, R2's medical record (received personal care and medication administration services) included a medication order for Oxycodone HCI Tablet 10mg, take one tablet every 6 hours, Oxycodone 10mg, take one tablet by mouth QID every 4 hours for pain, Morphine Sulfate Solution 20mg/1ml, take 0.25 ml under tongue every hour PRN, and Fentanyl dis 25 mcg/hr. Apply one patch topically on left... q 72 hours. R2's medication administration record (MAR) dated January 2025 through February 5, 2025, included documentation R2 received the Opioid medication, as prescribed. R2's medical record did not include documentation of an active malignancy or end of life condition, and did not include documentation of an identification of the resident's need for the opioid before the opioid was administered, and the monitoring of the effect of the opioid administered.
2. In observation, R2's medications were observed on site.
3. In documentation review, a facility policy, titled, "Opioid Medications, ...." documented, "... Before administering an opioid.. a trained certified caregiver identifies the resident's need for the opioid... using the "pain Scale" assessment tool... Resident's pain is identified and documented on the medication administration records... Caregivers will monitor the resident's response to any opioid administered..."
4. During an interview, E1 reported the opioid medication was administered to R2 daily, as ordered, and on an as needed basis, as ordered, for pain, and R2 did not have an active malignancy or an end of life condition. E1 and E3 acknowledged the caregivers were not trained on opioid medication administration, and did not document the resident's need for the opioid before the opioid was administered, and the monitoring of the effect of the opioid administered, as required by R9-10-120.F.
Summary:
The following deficiencies were found during the on-site compliance inspection and investigation of complaint AZ00215298, conducted on July 7, 2025: